Report Highlights
The global market for chromatography instruments and reagents should grow from $9.8 billion in 2018 to $14.0 billion in 2023 at a compound annual growth rate (CAGR) of 7.3% from 2018 to 2023.
Report Includes
- 47 data tables and 44 additional tables
- An overview of the global market for chromatography in pharmaceuticals and biotechnology applications
- Analyses of global market trends with data from 2016 and 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Characterization and quantification of market potential for chromatography instruments and reagents by technology type, application and geographical region
- Identification of the segments that should experience high growth during the time frame covered
- Information on competitor initiatives, and information pertaining to research and development status of chromatography in pharmaceuticals and biotechnology
- Coverage of significant patents and their allotments in each category
- Comprehensive profiles of major players in the industry, including Bio-Rad Laboratories Inc., Danaher Corp., MilliporeSigma, Qiagen, N.V., Scion Instruments and Thermo Fisher Scientific Inc.
Report Scope
According to the BCC Research report BIO011G Separation Systems for Commercial Biotechnology, chromatography accounted for nearly 21% of the overall market in 2015. In another BCC report, MST034E Global Markets for Reagents for Chromatography, the market that was valued at $7.6 billion in 2014 is estimated to reach $10.7 billion by 2019, growing at a compound annual growth rate (CAGR) of 5.2% through 2019. Chromatography is a valuable tool particularly in the pharmaceutical and biotechnology sectors as it can provide highly sensitive information about product quality and purity. The implementation of process analytical technology has also given a boost to this market. The growing demands of biopharmaceuticals, particularly monoclonal antibodies, biosimilar drugs and others have also necessitated biotechnology and biopharmaceutical industries to invest in high-throughput bioprocessing and downstream processing instruments. The advances in technology for the development of improved systems, innovative and disposable columns, better-performing resins, and other accessories are helping this market to grow significantly.
This BCC report provides a comprehensive analysis of the chromatography market in the global context, including market forecasts and sales through 2023. The report includes assessment of the chromatography market by segmenting it into the broad categories of instruments and reagents followed by thorough analyses of various techniques of chromatography for each category. These include liquid chromatography (ion-exchange, hydrophobic-interaction, size-exclusion, flash), high-pressure liquid chromatography (HPLC)/ultra-high-pressure liquid chromatography (UHPLC), thin layer chromatography, gas chromatography, supercritical fluid chromatography and affinity chromatography. This study surveys the chromatography market in all the geographic regions including North America, Europe and emerging markets. The emerging markets include countries such as India, China, Korea, Taiwan, Africa, Australia, New Zealand, Canada, Latin America and others. BCC Research has analyzed the chromatography market by applications in the pharmaceutical and biotechnology sectors.
Chromatography is a continuously evolving technique, and its success is dependent on the innovations in technology. Therefore, this report discusses the emerging trends in chromatography technology, particularly the instruments and the reagents. It also features the new developments and new product launches in the global market.
The report provides relevant patent analyses and comprehensive profiles of market players in the industry. The Industry Structure chapter focuses on the important chromatography instruments and reagent manufacturers and suppliers, their market shares and product offerings. The chapter also covers the mergers and acquisitions and any other collaborations or partnerships that happened during the evaluation period of this report that are expected to shape the industry.
BCC’s new report on chromatography elaborates on the strengths, weaknesses, threats and opportunities of the global chromatography market. Any regulatory changes or new initiatives are also highlighted.
Excluded from this report are the applications of chromatography in industries other than pharmaceutical and biotechnology such as chemicals, food and beverage, environment, oil and gas and others. Also, instruments and reagents for capillary electrophoresis and solid phase extraction (SPE) are not included. The sales for LC/MS instruments are not included as part of this study, although the systems are referred to in this report to show the uptake of liquid chromatography instruments in related applications.
Analyst Credentials
Dr. Kamna Jhamb has more than 13 years of research experience, of which more than four years have been devoted to market research. Before entering the field of market research, she worked as a Research Assistant in Lawrence Berkeley National Lab, CA. With a Ph.D. in Microbial Technology, she has vast knowledge in the areas of microbiology, protein chemistry, and molecular biology. She has several international publications in reputed journals. For BCC Research, Dr. Kamna has written reports spanning topics from healthcare, finance, to biotechnology.
Related Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Drug Discovery Technologies
The global market for drug discovery technologies is expected to grow from $111.9 billion in 2024 and is projected to reach $197.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.0% during the forecast period of 2024 to 2029.
Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging
The global market for contract pharmaceutical manufacturing, research and packaging is estimated to increase from $212.2 billion in 2023 to reach $310.2 billion by 2029, at a compound annual growth rate (CAGR) of 6.7% from 2024 through 2029.
Life Science Tools and Reagents: Global Markets
The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.
Recent Reports
Artificial Intelligence (AI) in Cancer
The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Induced Pluripotent Stem Cells: Global Markets
The global market for induced pluripotent stem cells (iPSCs) is expected to grow from $3.4 billion in 2023 to reach $5.2 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.1% from 2023 to 2028.
Commercial Amino Acids
The global market for commercial amino acids was valued at $30.1 billion in 2023. It is expected to grow from $31.8 billion in 2024 to $42.8 billion by 2029, at a compound annual growth rate (CAGR) of 6.1% from 2024 through 2029.
Top Trending Reports
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More